𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bioactive hydroxyapatite coatings on polymer composites for orthopedic implants

✍ Scribed by C. Auclair-Daigle; M. N. Bureau; J.-G. Legoux; L'H. Yahia


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
607 KB
Volume
73A
Category
Article
ISSN
1549-3296

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Hydroxyapatite [HA, Ca~10~(PO~4~)~6~(OH)~2~] coatings on polymer composite substrates were investigated for their bioactivity and their physicochemical and mechanical characteristics. HA holds key characteristics for use in orthopedic applications, such as for coating of the femoral stem in a hip replacement device. The plasma‐spray technique was used to project HA onto a carbon fiber/polyamide 12 composite substrate. The resulting HA coatings exhibited mechanical adhesion as high as 23 MPa, depending on the surface treatment of the composite substrate. The purpose of this investigation was to evaluate the bioactivity of an HA‐coated composite substrate. HA‐ coated samples have been immerged in simulated body fluid (SBF) and maintained within a shaker bath for periods of 1, 7, 14, 21, and 28 days at 37°C. Scanning electron microscopy, energy dispersive X‐ray spectroscopy, and X‐ray diffraction techniques were performed on the samples before and after immersion into SBF. SBF was analyzed using inductively coupled plasma atomic emission spectrometry for element concentration and evaluation of the solution's purity. SBF conditioning led to the deposition of crystalline HA onto the surface of the coatings. The calcium‐to‐phosphorous ratios of initial HA coating and of newly deposited HA were respectively 1.72 and 1.65, close to the HA theoretical calcium/phosphorous value of 1.67. Results demonstrated that bioactive HA coatings were produced by plasma spraying, because SBF conditioning induced newly formed HA with high crystallinity. Mechanical adhesion of the HA coatings was not significantly affected upon SBF conditioning. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res, 2005


📜 SIMILAR VOLUMES


Comparison of Tantalum and Hydroxyapatit
✍ Mangal Roy; Vamsi Krishna Balla; Susmita Bose; Amit Bandyopadhyay 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 458 KB

## Abstract Over the years hydroxyapatite (HA) coatings have been used to improve biologic properties of Ti‐based load bearing metal implants. However, applicability of HA coated implants is subjected to physical stability of the HA phase and mechanical integrity of the coating‐substrate interface.

Hydroxyapatite and titania sol-gel compo
✍ Kim, Hae-Won ;Kim, Hyoun-Ee ;Salih, Vehid ;Knowles, Jonathan C. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 602 KB

## Abstract Hydroxyapatite (HA) composites with titania (TiO~2~) up to 30 mol % were coated on a titanium (Ti) substrate by a sol–gel route, and the mechanical and biological properties of the coating systems were evaluated. Using polymeric precursors, highly stable HA and TiO~2~ sols were prepared

A new approach to graft bioactive polyme
✍ Gérard Hélary; Flavie Noirclère; Josselin Mayingi; Véronique Migonney 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 346 KB

Integration of titanium implants into bone is only passive and the resulting fixation is mainly mechanical in nature, with anchorage failure. Our objective, to increase the biointegration of the implant and the bone tissue, could be obtained by grafting a bioactive ionic polymer to the surface of th

Plasma-sprayed hydroxyapatite coating on
✍ Ning Cao; Jianwen Dong; Qiangxiu Wang; Quansheng Ma; Feng Wang; Huaying Chen; Ch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 706 KB

## Abstract The bioactive hydroxyapatite (HA) coatings were successfully prepared on carbon/carbon composites (C/C) by means of sand‐blasting pretreatment and plasma‐spraying technology. X‐ray diffraction was employed to analyze the phase constitute of the coatings. Meanwhile, the bond strength bet

Effect of a prostaglandin EP4 receptor a
✍ K. Hayashi; A. Fotovati; S. Abu Ali; Y. Nakamura; M. Inagaki; M. Naito 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB 👁 1 views

## Abstract The agonist of the prostaglandin EP4 receptor can increase bone density in osteoporosis. Using ovariectomized (OVX) and sham‐operated (SO) rats, the effects of the EP4 receptor agonist, ONO‐4819, and hydroxyapatite (HA) on implant‐bone fixation in implants with a rough surface were inve